Anitha Somasundaram
Endocrinology, Diabetes & Metabolism · West Chester, PANPI 1750674909
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $475 and has fallen 81.6% since, to $88 in 2023. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in PA, where the typical reported total is $1,080.
Across 66 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$213
- Abbott$136
- Lilly USA, LLC$110
- Novo Nordisk$80
- AstraZeneca$77
- Medtronic$75
- plus $465 from 19 others
What the payments were for
- Food & beverage$1,157100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 9 | $213 |
| Abbott | 7 | $136 |
| Lilly USA, LLC | 6 | $110 |
| Novo Nordisk | 5 | $80 |
| AstraZeneca | 6 | $77 |
| Medtronic(2 entities) | 4 | $75 |
| Boehringer Ingelheim | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 4 | $60 |
| Amgen | 2 | $33 |
| AbbVie | 2 | $33 |
| Vivus LLC | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $30 |
| Radius Health, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Companion Medical, Inc. | 1 | $17 |
| Bigfoot Biomedical Inc | 1 | $16 |
| Bayer | 1 | $15 |
| Shire North American Group Inc | 1 | $15 |
| Merck | 1 | $13 |
| BD | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $11 |
| Tandem Diabetes Care, Inc. | 1 | $11 |
How this compares
$1,157 in reported general payments places this provider in the 50th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.
See all endocrinology, diabetes & metabolism providers in Pennsylvania →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 14 | $200 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in West Chester
- Matthew KaneWest Chester$577K
- Serge JabbourPhiladelphia$1.2M
- Vijay BahlPittsburgh$998K
- Geraldo SaavedraWhitehall$698K
- Jane MayrinPhiladelphia$628K
- Stephan KowalykGreensburg$591K
- Intekhab AhmedPhiladelphia$528K
- Swarna VarmaPittsburgh$520K
- James DickeHanover$425K
- Mitchell LazarPhiladelphia$358K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.